Indication
Nose reshaping
2 clinical trials
3 products
1 drug
Clinical trial
The Efficacy of Liposomal Bupivacaine in the Management of Post-operative Pain Following Septorhinoplasty: A Single-blinded, Prospective Clinical TrialStatus: , Estimated PCD: 2024-10-01
Product
Liposomal BupivacaineProduct
Bupivacaine + EpinephrineClinical trial
Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or SeptoplastyStatus: Recruiting, Estimated PCD: 2024-09-01
Product
RemimazolamDrug
Varlilumab